{ }
001122334455554433221100
001122334455554433221100

roche completes 1.5 billion acquisition of poseida therapeutics

Roche Holdings has finalized its tender offer to acquire Poseida Therapeutics for approximately $1.5 billion, agreeing to pay $9.00 per share for nearly 65 million shares, representing 66% of Poseida’s outstanding stock. The deal includes a potential additional payment of up to $4.00 per share. Following the acquisition, Poseida will become a wholly owned subsidiary of Roche, and its shares will be delisted from the Nasdaq Global Select Market.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.